The FDA reported on April 25 that two companies that manufacture Phenylephrine are also experiencing a delay in the drug’s production. Baxter, one of the manufacturers, has accelerated production and anticipates having Phenylephrine available in mid-May.
Sandoz, the other manufacturer, is experiencing a back order of 10mL and 5mL vials of Phenylephrine HCI injection due to excess demand for the drug. The company anticipates more availability by the end of May.
According to the report, American Regent Manufacturers’ parent company, Luitpold Pharmaceuticals, is developing a plan to allow manufacturing and distribution to resume as soon as possible.
Read the ASA release on Phenylephrine.
Related Articles on Drug Shortages:
Drug Shortage, Huge Markups Angering Hospital Pharmacists
Hospira Producing Propofol Again
American Society of Anesthesiologists Conducts Survey on Drug Shortages
